Questions to Ask Your Cystic Fibrosis Team: Lung Function, Infections and Nutrition Goals

The clinic corridor is quiet at eight in the morning, and a father is sitting with a folded sheet of paper on his knee. His daughter, six years old, is blowing into a tube in the next room while a physiologist coaches her to “push, push, push”. He has been to twelve of these appointments. He still leaves most of them realizing, in the car park, that the one thing he meant to ask never got asked.

That gap is common, and it is not a failure. A cystic fibrosis review packs spirometry, sputum cultures, weight checks, a dietitian, a physiotherapist and a physician into an hour or two. The good news is that the right questions to ask cystic fibrosis team members are fairly predictable, because the disease itself follows known patterns in the lungs, the airways’ microbial ecology and the gut.

What follows is a working list, organized the way clinics organize their thinking: lung function first, infections second, nutrition third, with a section on daily routines, one on common misunderstandings and one on when a phone call should not wait until the next visit.

What actually happens at a cystic fibrosis clinic review

Cystic fibrosis (CF) is an inherited condition in which a faulty CFTR protein, the channel that moves salt and water across cell surfaces, leaves mucus in the lungs, pancreas and other organs thick and sticky. Because it touches several organs at once, care is delivered by a team rather than one doctor, and a review is built around measurements.

A typical visit starts with height and weight, because growth and body mass are treated as vital signs in CF. Spirometry follows: you blow as hard and long as you can into a device that measures airflow. A sputum or throat swab sample is taken for culture, which means the lab grows whatever bacteria are present and reports them by name. Most centers also check oxygen saturation with a finger probe.

You then see, in some order, a physiotherapist who reviews airway clearance technique, a dietitian who looks at intake and enzyme use, a specialist nurse and a physician. Annual reviews add blood tests for vitamins, liver function and glucose handling, plus a chest X-ray or low-dose CT depending on the center’s protocol. MedlinePlus and Mayo Clinic describe this multidisciplinary structure as the standard of care rather than an optional extra.

Knowing the shape of the visit helps you place your questions. Lung-function questions belong with the physician or physiologist; technique questions with the physiotherapist; weight, enzyme and vitamin questions with the dietitian. If a number is quoted at you, ask for it to be written in your notes or patient portal. A figure you can see plotted over time is far more useful than one you half-remember from the corridor.

Questions to ask your cystic fibrosis team about lung function

The single number most CF conversations circle back to is FEV1, the forced expiratory volume in one second: how much air you can push out in the first second of a hard breath out. It is reported as a percentage of what a healthy person of your age, sex, height and ancestry would be expected to produce, so “FEV1 of 85 percent predicted” means 85 percent of that reference value.

Ask these:

• What is my FEV1 percent predicted today, and what was my best value over the past year?
• Is today’s result within my normal day-to-day variation, or is it a real change?
• Which reference equations does the lab use, and has that changed recently? A switch in equations can shift the percentage without any change in the lungs.
• What other measures are you watching: FVC (the total amount exhaled), or lung clearance index in younger children who cannot yet perform reliable spirometry?

Spirometry is effort-dependent. A poor night’s sleep, a head cold or a child who is simply bored can drag a result down. That is why teams talk about trends rather than single readings, and why a “best FEV1 in the last twelve months” is often used as the personal baseline against which a new result is judged. Cleveland Clinic notes that lung function is usually well preserved in early childhood and that decline, when it happens, is gradual and variable between people.

Younger children are a special case. Reliable spirometry is generally achievable from around school age; below that, teams rely on symptoms, cultures, growth and imaging. Ask what the plan is for tracking your child’s lungs until spirometry becomes dependable.

What a drop in FEV1 does and does not mean

A fall of a few percentage points on a single day is rarely acted on alone. Teams generally look for a sustained drop from personal best, often alongside more cough, more sputum, weight loss or a new organism on culture, before calling it a pulmonary exacerbation. An exacerbation is a flare of lung symptoms, usually infection-driven, that needs a step up in treatment.

The questions that matter here are about thresholds and plans:

• At what point of decline would you want to see me sooner, repeat the test or change treatment?
• If I do not recover to my previous best after a course of treatment, what happens next?
• Could something other than infection explain this: technique, allergy, asthma-like airway reactivity, or a problem with my sinuses driving cough?

Recovery is not guaranteed after every exacerbation. Some people return fully to baseline; others settle at a slightly lower level, and repeated events are one reason lung function tends to drift down over years. Mayo Clinic frames the goal of CF care as slowing that drift by treating flares promptly and keeping airways as clear as possible between them. Ask your team how they judge whether you have “recovered” and what they would do differently if the next event follows the same pattern.

It also helps to ask what you can influence. Adherence to airway clearance, nutrition, exercise and inhaled therapies all feed into FEV1 trends. Vaccination against influenza, COVID-19 and pneumococcus is routinely advised for people with chronic lung disease by the CDC. None of these is a promise of a particular number; together they are the levers the evidence shows are worth pulling.

Which infections matter in cystic fibrosis, and why cultures are taken every visit

Thick airway mucus is hard to clear, and bacteria settle into it. Over time, most people with CF carry a recognizable cast of organisms. Early on it is often Staphylococcus aureus and Haemophilus influenzae; later, Pseudomonas aeruginosa becomes common. Some people acquire less frequent but harder-to-treat organisms such as Burkholderia cepacia complex, Stenotrophomonas or non-tuberculous mycobacteria (NTM), a group of environmental bacteria related to, but distinct from, the tuberculosis bacterium.

Cultures are taken routinely, not just when you are unwell, because the first appearance of a new organism can be a window for treatment before it settles in permanently. NHS guidance describes this early approach to Pseudomonas as standard practice. Ask:

• What grew on my last culture, and is it new, intermittent or chronic?
• Was sensitivity testing done, meaning the lab checked which antibiotic classes the organism responds to?
• Have I ever been screened for NTM, and how often do you recommend it?
• If Pseudomonas is new, what is the plan to try to clear it, and how will we know whether it worked?

You are entitled to know the names on your culture report. Some people find them frightening; the more useful framing is that a named organism is a known quantity with a known set of treatment options, and that the team has almost certainly managed it many times.

Viruses matter too. Ordinary colds and influenza frequently trigger bacterial flares in CF, which is why teams emphasize hand hygiene, vaccination and early contact if a viral illness is not settling. Johns Hopkins highlights that the aim of infection management in CF is to reduce the frequency and severity of exacerbations over the long term rather than to sterilize the airway, which is not a realistic target.

Questions about exacerbations, antibiotics and hospital stays

Treating a flare usually means antibiotics chosen against the organisms on your recent cultures, intensified airway clearance and attention to nutrition, since infection burns calories. Antibiotics may be given by mouth, by inhalation (a nebulized or dry-powder form that reaches the airway directly) or intravenously, at home or in hospital, depending on severity. The choice of drug, route and duration belongs to your prescribing team and depends on your history and sensitivities, so the useful questions are about the process rather than the pharmacy.

• How do you decide between oral, inhaled and intravenous treatment for me?
• Can intravenous courses be given at home, and what would I or my family need to learn?
• How will we measure whether this course has worked: symptoms, FEV1, weight, or all three?
• Do I have a long-term intravenous access device, and what are the signs of a problem with it?
• What side effects should I report during treatment, especially hearing changes or kidney concerns with certain antibiotic classes?

Long-term or maintenance inhaled antibiotics are often used when Pseudomonas has become chronic, in cycles set by the team. Ask what the cycle is meant to achieve and how it will be reviewed.

Hospital stays raise their own questions: how infection control will be handled on the ward, whether you will have a single room, how airway clearance and exercise continue during admission, and who coordinates school, work or caregiving arrangements. Specialist CF nurses typically manage a large share of this coordination, from teaching line care to arranging home delivery of equipment.

One question worth asking before you ever need it: “If I feel worse over a weekend, who do I call and what will they want to know?” Having that answer written down converts a frightening situation into a procedure.

Cross-infection: what to ask about keeping organisms from spreading between people with CF

Some CF organisms, notably certain strains of Pseudomonas and Burkholderia, can pass from one person with CF to another through droplets and shared surfaces. This is why clinics segregate patients by culture status, schedule appointment times to avoid waiting-room mixing and ask people with CF not to gather closely in person. NHS advice is direct on this point: people with CF should avoid close contact with each other.

Families often find these rules puzzling until the reasoning is explained, so ask for the explanation:

• Which of my organisms are considered transmissible, and what precautions follow from that?
• How does this clinic separate patients, and what should I do if I recognize another CF family in a shared space?
• What are the hygiene rules for nebulizer equipment at home, and how often should parts be replaced?
• Are there situations, such as siblings who both have CF, where the team has specific advice?

The equipment questions matter more than they appear. Nebulizers and airway clearance devices sit damp between uses and can grow bacteria if not cleaned and dried properly. Manufacturers’ instructions and your physiotherapist’s guidance should line up; if they do not, ask.

Cross-infection rules are not a comment on anyone’s hygiene, and they are not a reason for isolation. Online communities, video calls and moderated peer-support programs let people with CF connect without physical proximity. Ask your team which support networks they consider reliable. The wider environment also comes up: hot tubs, stagnant water and soil are recognized sources of Pseudomonas and NTM, and Cleveland Clinic and others list them as reasonable things to be cautious about rather than to fear.

Cystic fibrosis nutrition goals: weight, enzymes, salt and vitamins

In most people with CF the pancreas cannot deliver digestive enzymes to the gut because its ducts are blocked by thick secretions; Cleveland Clinic notes this affects the large majority. The result is malabsorption: fat and protein pass through undigested, stools become bulky and greasy, and weight and growth suffer. Better nutrition in CF is associated with better lung function, which is why dietitians treat weight as a lung-health measure.

Pancreatic enzyme replacement therapy (PERT) supplies the missing enzymes as capsules taken with food. The amount is individualized by the dietitian and prescriber based on fat intake, symptoms and growth, and adjusted over time; the useful questions are about monitoring rather than numbers.

• What is my target weight, body mass index or, for a child, growth percentile, and how far am I from it?
• How do you judge whether my enzymes are working: symptoms, stool pattern, weight, or laboratory tests?
• When were my vitamin A, D, E and K levels last checked? These fat-soluble vitamins are poorly absorbed in CF and are usually supplemented.
• How much extra salt do I need, especially in hot weather or during sport? People with CF lose more salt in sweat, and MedlinePlus lists salty-tasting skin as a hallmark sign.
• Is a high-fat, high-calorie diet still the right target for me, or has that changed with newer treatments?

That last question is increasingly relevant. As CFTR modulator therapy improves absorption for some people, dietitians report shifting from “eat as much as possible” to more balanced targets to avoid excess weight gain. This is individual, and the dietitian should explain where you sit.

Infants and toddlers have their own agenda: feeding methods, enzyme delivery with breast milk or formula, and growth catch-up. Ask how growth will be tracked and what would prompt a change in plan.

Beyond the lungs: diabetes, bones, liver and sinus questions worth raising

CF is a whole-body condition, and several complications develop quietly. Knowing which screening tests exist lets you check that none has been missed.

CF-related diabetes (CFRD). Scarring of the pancreas eventually reduces insulin production in a meaningful share of adults. CFRD behaves differently from type 1 or type 2 diabetes and is picked up by an oral glucose tolerance test, in which blood sugar is measured before and two hours after a sugary drink. Annual screening from around age ten is standard in most guidelines. Ask when yours was last done and what the result was.

Bone density. Malabsorption of vitamin D and calcium, chronic inflammation and, in some, steroid exposure raise the risk of thin bones. A DXA scan measures bone density; ask if and when one is planned.

Liver. Thick bile can damage the liver over time. Annual liver blood tests and, in some centers, ultrasound are part of routine review. Ask what your liver results show.

Sinuses and nasal polyps. Chronic sinus disease is very common and can drive cough and infection in the lower airway. Ask whether your sinuses have been assessed and whether an ear, nose and throat referral is worthwhile.

Fertility and reproductive health. Most men with CF have absence of the vas deferens and are infertile without assisted techniques; women may have reduced fertility but often conceive. Mayo Clinic lists both as recognized features. These are legitimate clinic questions at any age from adolescence onwards.

Mental health. Anxiety and depression are more common in people with CF and their caregivers than in the general population, and many centers screen for both annually. Asking “do you screen for mood, and what support is available?” is as clinical a question as any about FEV1.

What does a good cystic fibrosis daily routine look like?

People searching for the “recommended daily routine” in CF usually want to know how much time the disease will take. The honest answer is that it depends on age, lung health and which treatments are prescribed, but the building blocks are consistent across guidelines.

Airway clearance. Techniques that loosen and move mucus, whether breathing exercises, a vibrating vest, an oscillating handheld device or manual percussion, are generally done at least once and often twice daily, more during a flare. NHS guidance describes this as a daily cornerstone of care. The physiotherapist chooses and periodically re-teaches the technique; ask for a review if it feels ineffective.

Inhaled therapies. Many people use a nebulized mucus-thinning agent, hypertonic saline (a strong salt solution that draws water into the airway), or inhaled antibiotics, usually timed before or after clearance. Ask about the order of your inhaled treatments; it is not arbitrary.

Enzymes with every meal and snack containing fat. Forgetting them is the most common nutrition problem clinics see.

Exercise. Regular aerobic activity is recommended because it aids mucus clearance, supports bone and muscle, and improves mood. It complements, rather than replaces, airway clearance.

Oral medicines, vitamins and, for eligible people, CFTR modulators, taken as the prescriber has set out.

Practical questions for the team: How long should my routine take on a normal day? Which parts are non-negotiable if I am short of time? How do I adapt on school trips, at work or when traveling? Is there a way to simplify the regimen without losing benefit? Treatment burden is a recognized problem in CF, and a good team will help you prioritize rather than simply adding tasks.

CFTR modulators: how they work and what to ask before and after starting

CFTR modulators are a class of oral medicines that act on the faulty CFTR protein itself rather than on the downstream consequences. Depending on the specific genetic variant, they may help the protein fold correctly and reach the cell surface (“correctors”) or help a channel that is in place open properly (“potentiators”). Because they target the root defect, they can improve sweat chloride, lung function and weight in eligible people. The NIH’s National Heart, Lung, and Blood Institute describes them as a major shift in CF care.

Eligibility depends on which CFTR variants you carry. More than 2,000 variants have been identified, according to NHLBI, and modulators are approved only for certain ones. Ask:

• Which two CFTR variants do I have, and is a modulator approved for my combination in my age group?
• If not, is any variant-specific testing or a clinical trial worth discussing?
• What monitoring is needed before and after starting, particularly liver blood tests and, in children, eye examinations?
• How soon are you likely to reassess FEV1, weight and sweat chloride after starting?
• Which of my other treatments will continue, and how will we decide whether any can be reviewed later?

Two cautions belong here. First, a modulator does not replace airway clearance, enzymes or infection surveillance; teams generally advise continuing established therapies and reviewing them only within the clinic setting. Second, responses vary between people, and any decision to start, continue, pause or change a modulator sits with the prescribing clinician who knows your history and interactions with other medicines.

Side effects and interactions are part of the conversation. Some modulators interact with common antibiotics and antifungals, and with certain foods. Ask for the interaction list to be reviewed whenever a new medicine is added.

Who these questions are for, and who is usually asked to wait

The question list in this article serves several audiences, and the emphasis shifts with the situation.

Newly diagnosed infants and their parents. Most children in the United States are now identified through newborn screening, followed by a sweat test that measures chloride in sweat and genetic testing; MedlinePlus describes this pathway. In the first year, questions cluster around feeding, enzymes, salt, growth, when airway clearance starts and how to recognize a chest infection in a baby who cannot describe symptoms. Lung-function questions come later, when spirometry is possible.

School-age children and teenagers. Here the focus widens to FEV1 trends, cultures, sport, school arrangements and, crucially, transition. Adolescents are usually encouraged to lead part of the appointment themselves, and many centers begin planned transfer to adult services in the late teens. Ask when your center starts that process.

Adults, including those diagnosed late. A minority of people receive a diagnosis in adulthood, often after years of unexplained sinus disease, pancreatitis or infertility. Their questions center on what the diagnosis changes now, screening for complications and modulator eligibility.

Who is asked to wait. Some questions have honest “not yet” answers. Reliable spirometry waits for the child to be able to perform it. Modulator therapy waits on approvals for specific variants and age groups, and on baseline blood tests. Decisions about clearing a newly cultured organism sometimes wait for a repeat sample to confirm it is real. A team that says “we will revisit this at the annual review” is usually applying a guideline interval, and it is fair to ask which one.

Caregivers and partners are part of the audience too. Ask how they can be included in education sessions and whether the center offers caregiver support.

Lung function, infection and nutrition measures at a glance

The table below pulls together the measurements a CF team tracks, what each tells you and the question that unlocks the most useful conversation about it. Intervals vary between centers and with your individual plan; the annual review is the point at which most of these are gathered together.

Measure	What it shows	Typical timing	Best question to ask
FEV1 percent predicted	Airflow in the first second of a forced breath out, relative to healthy reference values	Every clinic visit once spirometry is reliable	Is this within my normal variation or a real change from my best?
Sputum or throat culture	Which bacteria are present and which antibiotic classes they respond to	Every visit; extra during flares	Is anything new, and does it change the plan?
NTM screening	Presence of non-tuberculous mycobacteria	Usually annually, more if symptoms suggest	When was I last screened?
Weight, BMI or growth percentile	Nutritional status, closely linked to lung outcomes	Every visit	What is my target and how far am I from it?
Vitamins A, D, E, K	Fat-soluble vitamin absorption	Annually	Are any levels low or high, and does my supplement need review?
Oral glucose tolerance test	Screening for CF-related diabetes	Annually from around age ten	What was my result and what does it mean for my food and energy?
Liver blood tests	Early signs of CF-related liver disease or medicine effects	Annually; more with modulators	Anything to watch?
Bone density (DXA)	Risk of osteoporosis	Periodically from adolescence	Is a scan due?
Mood screening	Anxiety and depression in patient and caregiver	Annually in many centers	What support is available if I score high?

A practical habit: bring last year’s numbers to this year’s review, on paper or on your phone, and ask the team to fill in the new column with you. Watching your own trend lines is one of the most powerful forms of engagement available to a patient.

What the following weeks usually look like after a review or a change in treatment

Clinic visits rarely end with everything settled. More often they set something in motion, and knowing the usual shape of the next few weeks reduces anxiety.

After a routine review with stable results. Expect a summary letter or portal note, any prescription updates and a follow-up date. Ask how quickly culture results come back, since some organisms, especially NTM, can take several weeks to grow, and whether you will be contacted only if something changes or in every case.

After a new organism is found. Teams commonly repeat the sample and, for Pseudomonas, start an eradication attempt. Follow-up cultures over the subsequent months tell you whether it has cleared. Ask how many negative cultures the team wants before calling it cleared.

After treatment for an exacerbation. Symptom improvement usually comes first, with FEV1 re-measured at the end of the course to see how close you are to your previous best. Some centers schedule a review two to four weeks after finishing treatment. If you have not recovered, the conversation turns to whether the organism, the route or the duration needs rethinking.

After starting a CFTR modulator. Liver tests and a clinical review typically follow within the first months, with sweat chloride and lung function re-checked to gauge response. Some people notice changes in cough and sputum quickly; others take longer, and the team judges response over more than one visit. Ask what the plan is if you notice no change.

After a dietary or enzyme adjustment. Weight and symptoms are the readouts, usually reassessed at the next visit. Keeping a simple food, enzyme and stool diary for a fortnight gives the dietitian far more to work with than memory does.

Whatever the change, ask who to contact in the interval and what would make them want to see you sooner.

What people often get wrong about cystic fibrosis care

“A normal FEV1 means the lungs are fine.” Structural damage, especially in the small airways, can be present on CT before spirometry falls. That is why cultures, symptoms and imaging are tracked alongside the number.

“If I have Pseudomonas, nothing can be done.” Chronic Pseudomonas is common and manageable. Inhaled antibiotics, airway clearance and prompt treatment of flares are aimed at keeping it suppressed. A first isolation, moreover, is often treatable with the aim of clearing it, which is exactly why routine cultures exist.

“Modulators mean I can stop the rest.” No guideline supports dropping airway clearance or enzymes on your own. Any simplification of a regimen is a clinic decision made with monitoring.

“Being underweight is just part of CF.” Low weight is a treatable problem with a documented link to lung function, not an inevitability. If weight is stuck, ask for a dietitian review and a check on enzyme use, glucose handling and hidden infection.

“Cross-infection rules are excessive.” Person-to-person spread of certain strains between people with CF is well documented, and outbreaks in the past changed clinic design worldwide. The rules exist because they work.

“Carriers have a mild form.” Carriers have one faulty gene copy and one working copy, and do not have CF. NHS notes that about 1 in 25 people of white European ancestry carry a CF variant. Carrier status matters for family planning, not for the carrier’s own lungs.

“Exercise replaces physiotherapy.” Exercise helps clearance and is strongly encouraged, but it is an addition to, not a substitute for, the prescribed technique.

“Life expectancy is a fixed number I can look up.” Registry figures describe predicted medians for a birth cohort under current care, and they have risen steadily. They cannot predict an individual, and your team will tell you honestly what the current estimates are and what they are based on.

Questions to ask your cystic fibrosis team: a checklist you can bring to clinic

Bring this list, cross out what does not apply and add your own. Ask the nurse to note the answers.

Lung function

• What is my FEV1 today and my best this year?
• Is today’s result a real change?
• What would prompt you to see me sooner?

Infections

• What grew on my last culture, and is it new or chronic?
• When was I last screened for NTM?
• How do you define an exacerbation for me, and how will we judge recovery?
• Who do I call out of hours?

Nutrition

• What is my weight or growth target?
• When were my vitamins, liver tests and glucose tolerance test last done?
• Do my enzymes need review, and how will we tell?

Treatments and routine

• Which parts of my daily routine matter most if time is short?
• Which CFTR variants do I have, and what does that mean for modulator eligibility?
• Are there interactions between my medicines I should know about?

Nursing and coordination

• What do the specialist nurses handle, from line care teaching and home intravenous set-up to infection-control education and school liaison, and how do I reach them?

Life stage and support

• When does transition to adult services begin here, and what does it involve?
• What do current registry data say about life expectancy, and what are those figures based on?
• Which patient organizations, registries, financial-navigation services and peer-support programs do you consider reliable?
• Do you screen for anxiety and depression, and what support follows?

You will not get through all of these in one visit, and you do not need to. Pick the three that are keeping you awake and start there. The rest can wait for the annual review, which is designed to be the long conversation.

When to call your doctor

Most CF teams would rather hear from you early than see you late. Between visits, contact the team the same day if you notice a sustained increase in cough or sputum, a change in sputum color or thickness, new breathlessness with usual activity, fever, chest pain, unexplained weight loss or reduced appetite lasting more than a few days, or a fall on a home spirometer if you use one. In an infant or young child, faster breathing, poor feeding, fewer wet diapers or unusual lethargy warrant a call.

Seek emergency care without waiting for a callback if you cough up more than a small streak of blood, especially a mouthful or repeated episodes; if you develop sudden sharp chest pain with breathlessness, which can signal a collapsed lung (pneumothorax); if lips or fingertips look blue or gray; if breathing is so hard that you cannot speak in full sentences; if you have severe abdominal pain with vomiting or a swollen, hard abdomen, which can indicate a bowel blockage that people with CF are prone to; or if confusion, extreme drowsiness or signs of severe dehydration appear, particularly in hot weather when salt loss is high.

Symptoms of high or very low blood sugar in someone known to have CF-related diabetes also need prompt contact. If you have a long-term intravenous line, redness, swelling, pain along the line or fever should be reported straight away.

None of these lists replaces your team’s own instructions, which are tailored to your history. Keep the clinic and out-of-hours numbers in your phone, and let the team decide the next step.

Frequently asked questions

What are the recommended daily routines for someone with cystic fibrosis?

A typical day includes airway clearance at least once and often twice, inhaled therapies timed around clearance, pancreatic enzymes with every meal or snack containing fat, vitamins, extra salt in hot weather or with exercise, regular aerobic activity and any prescribed oral medicines. The exact mix and time commitment depend on age, lung health and treatments; the physiotherapist and dietitian tailor it and should be asked which elements matter most when time is short.

What are the nursing interventions for a patient with cystic fibrosis?

Specialist CF nurses coordinate care between disciplines, teach and check airway clearance and nebulizer hygiene, educate on infection control, train families in home intravenous antibiotic administration and line care, monitor for side effects, arrange equipment and supplies, liaise with schools and employers, support transition from pediatric to adult services and act as the first point of contact when symptoms change. Ask your center how to reach the nursing team directly.

What is the average life expectancy for people with cystic fibrosis?

Life expectancy in CF has risen markedly over recent decades and continues to improve as earlier diagnosis, aggressive infection management, nutrition and CFTR modulator therapy have become standard, according to NIH and MedlinePlus. Published figures are registry-based median predictions for a birth cohort under current care, not forecasts for an individual. Your team can tell you the current estimate and what it rests on, and how your own results compare.

What resources are available for people with cystic fibrosis?

Reliable resources include national CF patient organizations and registries, accredited CF care centers with multidisciplinary teams, specialist nurses and social workers who help with school, work and insurance navigation, moderated online peer communities that respect cross-infection rules, mental-health screening and referral, and plain-language information from MedlinePlus, the NIH and the NHS. Ask your team which local and national resources they recommend for your situation.

What does a cystic fibrosis lung function test measure?

Spirometry measures how much air you can force out and how fast. FEV1 is the volume exhaled in the first second, expressed as a percentage of the value expected for a healthy person of your age, sex, height and ancestry. FVC is the total volume exhaled. In young children unable to perform spirometry, some centers use lung clearance index, a gentler test of how evenly air moves through the lungs.

How often should someone with cystic fibrosis see their care team?

Most guidelines recommend routine multidisciplinary review roughly every one to three months, with a fuller annual review that adds blood tests, glucose tolerance testing, imaging and screening for complications. Infants and people with unstable disease are usually seen more often. Your center sets the interval based on your age, lung function trend, culture results and current treatments, and will bring you in sooner if symptoms change.

What are realistic cystic fibrosis nutrition goals?

Goals are individual, but teams generally aim for a body mass index in the healthy-to-upper-normal range for adults and normal growth percentiles for children, because better nutrition is linked to better lung function. Enzymes are adjusted to control malabsorption symptoms, fat-soluble vitamins are supplemented and monitored yearly, salt intake is increased, and glucose handling is screened annually. As modulators improve absorption for some people, dietitians may revise targets to avoid excess weight gain.

Why do people with cystic fibrosis have to avoid each other?

Certain bacterial strains, including some Pseudomonas aeruginosa and Burkholderia cepacia complex strains, can spread between people with CF through droplets and shared surfaces and are harder to treat once acquired. Because of documented outbreaks, clinics separate patients by culture status and advise against close in-person contact between people with CF. The guidance is about specific organisms, not hygiene, and online and remote peer support remain safe ways to connect.

What is a pulmonary exacerbation in cystic fibrosis?

A pulmonary exacerbation is a flare of lung symptoms, usually driven by infection, that needs a step up in treatment. Teams look for a combination of increased cough or sputum, breathlessness, fatigue, reduced appetite or weight, and a sustained fall in FEV1 from personal best. Treatment typically involves antibiotics chosen against recent cultures, intensified airway clearance and nutritional support, with lung function re-measured afterwards to check recovery toward baseline.

When should a child with cystic fibrosis start transition to adult care?

Many centers begin planned transition in the early to mid teens, encouraging the young person to lead parts of the appointment, understand their own results and medicines, and meet the adult team before transfer, which commonly occurs around the late teens. The exact timing depends on maturity, health stability and local service structure. Ask your pediatric team when their process starts and what milestones they use.

References

• MedlinePlus: Cystic Fibrosis
• NHS: Cystic fibrosis
• Cleveland Clinic: Cystic Fibrosis
• NIH National Heart, Lung, and Blood Institute: Cystic Fibrosis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.